What is the recommended tetanus vaccination schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Vaccination Schedule

The recommended tetanus vaccination schedule includes a primary series in childhood followed by Tdap at age 11-12 years and booster doses of either Td or Tdap every 10 years throughout life to ensure continued protection against tetanus and diphtheria. 1

Childhood Vaccination Schedule

  • The primary series for tetanus vaccination consists of three doses administered at 4-8 week intervals, followed by a fourth (reinforcing) dose 6-12 months after the third dose 1
  • The fourth dose may be administered as early as 12 months of age if at least 6 months have elapsed since the third dose 1
  • A fifth dose is typically given at 4-6 years of age as part of the childhood immunization schedule 1

Adolescent and Adult Vaccination

  • Persons aged 11-18 years should receive a single dose of Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis), preferably at age 11-12 years 1
  • After receiving Tdap, booster doses of either Td or Tdap should be administered every 10 years throughout life to maintain protection 1
  • Adults aged ≥19 years who have never received Tdap should get one dose of Tdap regardless of when they last received a tetanus-containing vaccine, followed by either Td or Tdap boosters every 10 years 1

Special Populations

Pregnant Women

  • Pregnant women should receive one dose of Tdap during each pregnancy, regardless of prior vaccination history 1
  • Tdap should be administered between 27-36 weeks' gestation, preferably during the earlier part of this period 1

Wound Management

  • For tetanus-prone wounds, a tetanus toxoid-containing vaccine is indicated when >5 years have passed since the last tetanus toxoid-containing vaccine dose 1
  • For persons ≥11 years who have not previously received Tdap or whose Tdap history is unknown, Tdap is preferred over Td for wound management 1
  • For pregnant women requiring tetanus prophylaxis for wound management, Tdap should be used 1

Catch-up Vaccination

Children and Adolescents (7-18 years)

  • Unvaccinated persons aged 7-18 years should receive a series of three tetanus and diphtheria toxoid-containing vaccines, which includes at least 1 Tdap dose 1
  • The preferred schedule is 1 dose of Tdap, followed by 1 dose of either Td or Tdap ≥4 weeks afterward, and 1 dose of either Td or Tdap 6-12 months later 1

Adults (≥19 years)

  • Unvaccinated adults should receive a series of three tetanus and diphtheria toxoid-containing vaccines, which includes at least 1 Tdap dose 1
  • The preferred schedule is 1 dose of Tdap, followed by 1 dose of either Td or Tdap at least 4 weeks afterward, and 1 dose of either Td or Tdap 6-12 months later 1

Important Considerations

  • The vaccination series does not need to be restarted for those with incomplete history, regardless of the time elapsed between doses 1
  • Recent evidence suggests that after completing the childhood vaccination series, decennial booster vaccinations may not be necessary for maintaining protective immunity in the general population 2, 3
  • However, current ACIP guidelines still recommend the 10-year booster schedule to ensure continued protection 1
  • Tetanus toxoid is highly effective, with disease incidence falling to less than one case per 10 million person-years in countries with robust vaccination programs 2

Pitfalls to Avoid

  • Do not administer DTaP to persons aged ≥7 years; use Tdap or Td instead 1
  • Do not miss the opportunity to administer Tdap to adults who have never received it, regardless of when they last received Td 1
  • Avoid unnecessary administration of tetanus toxoid for minor, clean wounds in fully immunized individuals (≥3 doses) if the last dose was given within 10 years 4, 5
  • Remember that tetanus immunoglobulin should be reserved for patients with wounds who have never received primary immunization against tetanus 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Research

Tetanus and trauma: a review and recommendations.

The Journal of trauma, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.